1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Rockwell Medical, Inc.

Rockwell Medical, Inc.

RMTI
Rockwell Medical, Inc.US flagNASDAQ Capital Market
0.71
USD
-0.01
- -
27.99MMarket Cap

Total Valuation

Rockwell Medical, Inc. carries a market capitalization of 26.67M, placing it among publicly traded companies globally. Its enterprise value stands at 23.81M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap26.67M
Enterprise Value23.81M

Share Statistics

Rockwell Medical, Inc. currently has 39.47M shares outstanding.

Shares Outstanding39.47M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.49, and the price-to-book ratio stands at -0.08.

PE RatioN/A
PS Ratio0.49
PB Ratio-0.08
P/TBV Ratio1.31
P/FCF Ratio9.34
P/OCF Ratio12.52

Enterprise Valuation

On an enterprise value basis, Rockwell Medical, Inc. trades at an EV/EBITDA multiple of 27.55 and an EV/FCF ratio of 6.19.

EV / Sales0.35
EV / EBITDA27.55
EV / EBITN/A
EV / FCF6.19

Financial Position

Rockwell Medical, Inc. maintains a current ratio of 3.74, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.13, indicating elevated leverage, while an interest coverage ratio of -9.39 demonstrates limited ability to service its debt obligations.

Current Ratio3.74
Quick Ratio3.32
Debt / Equity40.13
Debt / EBITDA-5.44
Interest Coverage-9.39

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-9.70
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover13.86

Stock Price Statistics

Rockwell Medical, Inc.'s stock has declined approximately -33.09901% over the past 52 weeks. The 50-day moving average sits at 0.87, while the 200-day moving average is 1.04.

Beta (5Y)N/A
52-Week Price Change-33.09901%
50-Day Moving Average0.87
200-Day Moving Average1.04
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Rockwell Medical, Inc. generated 67.68M in revenue and converted that into -5.40M in net income, yielding earnings per share of -0.14. EBITDA reached -2.65M, while operating income came in at -4.81M.

Revenue67.68M
Gross Profit11.55M
Operating Income-4.81M
Pretax Income-5.40M
Net Income-5.40M
EBITDA-2.65M
EBIT-4.81M
Earnings Per Share (EPS)-0.14

Balance Sheet

Rockwell Medical, Inc. holds 23.89M in cash and equivalents against 14.39M in total debt, resulting in a net debt position of -629,000.00. Total book value stands at -404.59M, with working capital of 27.08M providing operational flexibility.

Cash & Cash Equivalents23.89M
Total Debt14.39M
Net Debt-629,000.00
Equity (Book Value)-404.59M
Book Value Per Share-10.85
Working Capital27.08M

Cash Flow

Rockwell Medical, Inc. produced 2.66M in operating cash flow over the past twelve months. After subtracting -904,000.00 in capital expenditures, free cash flow totaled 1.76M - equivalent to 0.05 per share.

Operating Cash Flow2.66M
Capital Expenditures-904,000.00
Free Cash Flow1.76M
FCF Per Share0.05

Margins

Rockwell Medical, Inc. operates with a gross margin of 17.07, reflecting its pricing power and cost economics. The operating margin of -7.11 and net profit margin of -7.98 provide insight into operational efficiency.

Gross Margin17.07
Operating Margin-7.11
Pretax Margin-7.98
Profit Margin-7.98
EBITDA Margin-3.91

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-12.68
FCF Yield10.70

Stock Splits

Rockwell Medical, Inc.'s most recent stock split took place on May 13, 2022 with a 11:1 split ratio.

Last Split Date5/13/2022
Split Ratio11:1

Scores

Rockwell Medical, Inc. posts an Altman Z-Score of -9.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-9.34